55 related articles for article (PubMed ID: 36881825)
1. CD30+ lymphoproliferative disorder masquerading as an atypical melanocytic proliferation.
Hernandez-Rovira MA; Lama CM; Musiek ACM; Russell AJ
J Cutan Pathol; 2023 Dec; 50(12):1048-1051. PubMed ID: 37666504
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous lymphoproliferative disorders after COVID-19 vaccination: clinical presentation, histopathology, and outcomes.
Gordon ER; Kwinta BD; Schreidah CM; Fahmy LM; Adeuyan O; Queen D; Trager MH; Magro CM; Geskin LJ
Leuk Lymphoma; 2024 Jan; 65(1):48-54. PubMed ID: 37861685
[TBL] [Abstract][Full Text] [Related]
3. Risk of systemic lymphoma in patients with cutaneous CD30+ lymphoproliferative disorders: A single center retrospective cohort analysis.
Chen J; Martinez A; Shinohara MM
J Am Acad Dermatol; 2024 Mar; ():. PubMed ID: 38490370
[No Abstract] [Full Text] [Related]
4. A wolf in sheep's clothing: enteropathy associated T-cell lymphoma involving a nasal polyp masquerading as primary mucosal CD30-positive T-cell lymphoproliferative disorder.
Attygalle AD; Vroobel KM; Madej E; Tzioni MM; Zhang C; Chen Z; Ribeiro S; Calvachini S; Sharma B; Alexander EJ; Wotherspoon AC; Du MQ
Histopathology; 2024 Jun; 84(7):1238-1241. PubMed ID: 38383998
[No Abstract] [Full Text] [Related]
5. Disseminated necrotic plaques in a 50-year-old man.
Müller VL; Hillen U; Schaller J; Duschner N; Hyun J; Schrickel I; Kreuter A
J Dtsch Dermatol Ges; 2024 May; ():. PubMed ID: 38719550
[No Abstract] [Full Text] [Related]
6. CD30-Positive Lymphoproliferative Disorders.
Nikolaenko L; Zain J; Rosen ST; Querfeld C
Cancer Treat Res; 2019; 176():249-268. PubMed ID: 30596222
[TBL] [Abstract][Full Text] [Related]
7. CD30-positive primary cutaneous lymphoproliferative disorders: molecular alterations and targeted therapies.
Prieto-Torres L; Rodriguez-Pinilla SM; Onaindia A; Ara M; Requena L; Piris MÁ
Haematologica; 2019 Feb; 104(2):226-235. PubMed ID: 30630983
[TBL] [Abstract][Full Text] [Related]
8. The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30+ lymphoproliferative disorders: comparison with anaplastic large-cell lymphoma of nodal origin.
DeCoteau JF; Butmarc JR; Kinney MC; Kadin ME
Blood; 1996 Apr; 87(8):3437-41. PubMed ID: 8605362
[TBL] [Abstract][Full Text] [Related]
9. Primary Cutaneous CD30+ Lymphoproliferative Disorders: a Comprehensive Review.
Di Raimondo C; Parekh V; Song JY; Rosen ST; Querfeld C; Zain J; Martinez XU; Abdulla FR
Curr Hematol Malig Rep; 2020 Aug; 15(4):333-342. PubMed ID: 32435988
[TBL] [Abstract][Full Text] [Related]
10. A Case-Based Review of Cutaneous CD30-Positive Lymphoproliferative Disorders.
Felts C; Tjarks BJ
S D Med; 2022 Sep; 75(9):402-409. PubMed ID: 36881825
[TBL] [Abstract][Full Text] [Related]
11. CD30-positive lymphoproliferative disorders-An Australian Clinical Practice Statement from the Peter MacCallum Cancer Centre.
Bhabha FK; McCormack C; Campbell BA; Lade S; Buelens O; Van Der Weyden C; Prince HM
Australas J Dermatol; 2023 May; 64(2):194-203. PubMed ID: 36892928
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
